The
nanotechnology drug delivery market involves the utilization of nanocarriers
for delivering drug molecules to targeted sites in a controlled manner.
Nanoparticles act as carriers for targeted drug delivery by encapsulating or
entrapping drug molecules and releasing them in a sustained or controlled
manner at the targeted site of action. This approach allows for controlled
manipulation of properties like solubility, biodistribution, pharmacokinetics,
and safety of drug molecules. The use of nanocarriers helps in overcoming
issues like poor solubility, stability, bioavailability, and premature
metabolism of drug payloads. Nanotechnology-based drug delivery offers benefits
like enhanced therapeutic efficacy, controlled rate and site-specific release
of drugs, reduction in dosing frequency and side effects.
The
Global nanotechnology drug delivery market is estimated to be valued at US$
203.21 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast
period 2024 to 2031.
Key Takeaways
Key players operating in the nanotechnology drug delivery are AbbVie Inc.,
Geistlich Pharma AG, Alkermes plc, Amgen Inc., AngioDynamics Inc., Arrowhead
Pharmaceuticals Inc., BIND Therapeutics Inc., Capsulution Nanoscience AG,
Celgene Corporation, Johnson & Johnson, Nanobiotix, Nanocarrier Co. Ltd.,
Merck & Co. Inc., Novartis International AG, Pfizer Inc., Sanofi SA,
SkyePharma PLC, Starpharma Holdings Limited, Teva Pharmaceutical Industries
Ltd. The demand for nanotechnology drug delivery systems is increasing owing to
growing demand for targeted drug therapies and controlled drug delivery
approaches. Technological advancements in the field of nanomedicine,
biomaterials and drug delivery vehicles like liposomes, polymeric
nanoparticles, metallic nanoparticles, micelles, dendrimers are further fueling
market growth.
Market Trends
Development of multifunctional drug delivery systems capable of co-delivering
drug and gene payloads is a key trend in the market. These novel platforms
offer synergistic therapeutic outcomes. Growing focus on developing
stimuli-responsive 'smart' nanocarriers that can sense changes in biological
microenvironment and release drug in response is another major trend. These
emerging delivery strategies hold potential to precisely deliver drugs
on-demand at target sites.
Market Opportunities
Untapped therapeutic applications and several drugs in pipeline indicate
expansion opportunities in the domain of cancer therapy.
Nanotechnology
Drug Delivery Market Demand Growing incidence of cancer coupled with
need for personalized medicine approaches present attractive opportunities.
Incorporating diagnostic functionality along with therapeutic efficacy in single
nanocarrier platforms presents lucrative opportunities in theranostics domain.
Commercialization of FDA approved nanomedicines also indicates scope of market
growth.
Impact of COVID-19 on Nanotechnology Drug Delivery Market
The COVID-19 pandemic has significantly impacted the nanotechnology drug
delivery market. During the initial outbreak, research and development
activities were halted as resources were diverted towards developing vaccines
and treatments for COVID-19. This led to delays in clinical trials for various
nanomedicine applications. However, post the first wave, research has regained
momentum as nanotechnology shows promise in developing antiviral strategies
against SARS-CoV-2. Various nanocarriers are being investigated for efficient delivery
of antiviral drugs and immune system stimulators to combat COVID-19. Some key
areas where nanotechnology is playing a role include development of
nanomedicines for drug repurposing, nano-based diagnostic techniques and
nanoparticle incorporated face masks. Overall, while the pandemic stalled short
term growth initially, nanotechnology is now poised to make significant
contributions in antiviral strategies, boosting the long term prospects of this
market.
North America has the highest concentration of nanotechnology drug delivery
market in terms of value currently. The region accounted for over 40% share of
the global market revenue in 2024 due to presence of advanced healthcare
infrastructure and huge investments in research & development activities.
The Asia Pacific region is projected to be the fastest growing market during
the forecast period from 2024 to 2031. This is attributed to rising healthcare
expenditure, growing demand for advanced treatment options and increasing
collaborations between regional and international players. Countries like
China, India and South Korea are anticipated to be the major drivers of
nanotechnology drug delivery market growth in Asia Pacific.
Get more insights on – Nanotechnology
Drug Delivery Market
About Author:
Money Singh is a seasoned content writer with over
four years of experience in the market research sector. Her expertise spans
various industries, including food and beverages, biotechnology, chemical and
materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)
Comments
Post a Comment